Dutalys' Acquisition

Dutalys was acquired by Roche Holding on December 19, 2014.

Dutalys specializes in the discovery and development of fully human, bi-specific antibodies based on their proprietary DutaMab technology. The bi-specific antibodies developed with this platform are d…

Articles about Dutalys' Acquisition: